Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Medicine | 11 | 2024 | 41 | 3.200 |
Why?
|
| Lung Neoplasms | 17 | 2023 | 674 | 2.580 |
Why?
|
| Bronchoscopy | 14 | 2022 | 90 | 2.400 |
Why?
|
| Tracheostomy | 4 | 2021 | 36 | 1.570 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 5 | 2023 | 166 | 1.570 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 3 | 2020 | 14 | 1.000 |
Why?
|
| Pleurodesis | 4 | 2019 | 9 | 0.980 |
Why?
|
| Respiratory Insufficiency | 2 | 2020 | 155 | 0.890 |
Why?
|
| Betacoronavirus | 3 | 2020 | 183 | 0.860 |
Why?
|
| Bronchoscopes | 2 | 2022 | 11 | 0.840 |
Why?
|
| Bronchial Diseases | 2 | 2022 | 13 | 0.840 |
Why?
|
| Tracheal Diseases | 2 | 2022 | 12 | 0.840 |
Why?
|
| Multiple Pulmonary Nodules | 1 | 2023 | 20 | 0.830 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 210 | 0.790 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 224 | 0.790 |
Why?
|
| Tomography, X-Ray Computed | 9 | 2021 | 1644 | 0.760 |
Why?
|
| Needles | 2 | 2022 | 67 | 0.740 |
Why?
|
| Amyloidosis | 1 | 2022 | 66 | 0.710 |
Why?
|
| Pneumonia | 2 | 2021 | 291 | 0.690 |
Why?
|
| Early Detection of Cancer | 5 | 2023 | 322 | 0.660 |
Why?
|
| Pleural Diseases | 1 | 2019 | 8 | 0.640 |
Why?
|
| Sclerosing Solutions | 1 | 2019 | 6 | 0.640 |
Why?
|
| Physicians | 2 | 2023 | 470 | 0.600 |
Why?
|
| Education, Medical, Graduate | 5 | 2024 | 351 | 0.580 |
Why?
|
| Career Choice | 2 | 2020 | 131 | 0.540 |
Why?
|
| Clinical Competence | 8 | 2024 | 727 | 0.500 |
Why?
|
| Humans | 46 | 2024 | 63429 | 0.500 |
Why?
|
| Pleural Effusion, Malignant | 4 | 2019 | 12 | 0.480 |
Why?
|
| Pandemics | 4 | 2021 | 672 | 0.470 |
Why?
|
| Fellowships and Scholarships | 3 | 2024 | 108 | 0.470 |
Why?
|
| Mass Screening | 4 | 2015 | 690 | 0.450 |
Why?
|
| Radiography, Thoracic | 2 | 2015 | 117 | 0.430 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 3 | 2022 | 15 | 0.410 |
Why?
|
| Catheters, Indwelling | 4 | 2018 | 69 | 0.400 |
Why?
|
| Accreditation | 3 | 2024 | 78 | 0.380 |
Why?
|
| Hypoxia | 1 | 2012 | 115 | 0.360 |
Why?
|
| Thoracoscopy | 3 | 2019 | 25 | 0.310 |
Why?
|
| Education, Medical, Continuing | 1 | 2010 | 96 | 0.310 |
Why?
|
| Consensus | 2 | 2020 | 214 | 0.300 |
Why?
|
| Teaching | 1 | 2010 | 159 | 0.300 |
Why?
|
| United States | 9 | 2024 | 7841 | 0.270 |
Why?
|
| Patient Selection | 3 | 2020 | 490 | 0.260 |
Why?
|
| Societies, Medical | 5 | 2020 | 379 | 0.250 |
Why?
|
| Lung | 2 | 2020 | 954 | 0.230 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2021 | 698 | 0.220 |
Why?
|
| Hospitalization | 2 | 2021 | 1361 | 0.210 |
Why?
|
| Probability | 1 | 2023 | 170 | 0.210 |
Why?
|
| Retrospective Studies | 11 | 2022 | 6658 | 0.210 |
Why?
|
| Suction | 1 | 2022 | 36 | 0.190 |
Why?
|
| Bronchial Thermoplasty | 1 | 2021 | 1 | 0.190 |
Why?
|
| Mediastinum | 1 | 2022 | 29 | 0.180 |
Why?
|
| Talc | 2 | 2019 | 5 | 0.180 |
Why?
|
| Teacher Training | 1 | 2021 | 4 | 0.180 |
Why?
|
| Torsades de Pointes | 1 | 2021 | 6 | 0.180 |
Why?
|
| Female | 20 | 2023 | 32871 | 0.180 |
Why?
|
| Clinical Protocols | 2 | 2020 | 131 | 0.180 |
Why?
|
| Hydroxychloroquine | 1 | 2021 | 21 | 0.180 |
Why?
|
| Vascular Calcification | 1 | 2021 | 26 | 0.170 |
Why?
|
| Learning Curve | 1 | 2021 | 35 | 0.170 |
Why?
|
| Lymph Nodes | 1 | 2022 | 226 | 0.170 |
Why?
|
| Pectoralis Muscles | 1 | 2020 | 8 | 0.170 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 311 | 0.170 |
Why?
|
| Pulmonary Surgical Procedures | 1 | 2020 | 1 | 0.170 |
Why?
|
| Emphysema | 1 | 2020 | 39 | 0.170 |
Why?
|
| Water | 1 | 2022 | 309 | 0.170 |
Why?
|
| Aged | 15 | 2021 | 14432 | 0.160 |
Why?
|
| Specimen Handling | 1 | 2020 | 62 | 0.160 |
Why?
|
| Male | 20 | 2023 | 29893 | 0.160 |
Why?
|
| Silver Nitrate | 1 | 2019 | 1 | 0.160 |
Why?
|
| Povidone-Iodine | 1 | 2019 | 5 | 0.160 |
Why?
|
| Tetracyclines | 1 | 2019 | 6 | 0.160 |
Why?
|
| Dexamethasone | 1 | 2021 | 205 | 0.160 |
Why?
|
| Smoking | 4 | 2014 | 866 | 0.160 |
Why?
|
| Infection Control | 1 | 2020 | 106 | 0.160 |
Why?
|
| Prostheses and Implants | 1 | 2019 | 71 | 0.160 |
Why?
|
| Pneumothorax | 1 | 2019 | 50 | 0.150 |
Why?
|
| Pulmonary Emphysema | 1 | 2019 | 108 | 0.150 |
Why?
|
| Hydrothorax | 1 | 2018 | 5 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 2018 | 32 | 0.150 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 297 | 0.140 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 312 | 0.140 |
Why?
|
| Asthma | 1 | 2021 | 459 | 0.130 |
Why?
|
| Middle Aged | 13 | 2021 | 17598 | 0.130 |
Why?
|
| Forced Expiratory Volume | 2 | 2019 | 209 | 0.130 |
Why?
|
| Curriculum | 2 | 2020 | 598 | 0.130 |
Why?
|
| Drainage | 1 | 2017 | 154 | 0.130 |
Why?
|
| Mediastinal Neoplasms | 1 | 2016 | 20 | 0.120 |
Why?
|
| Conscious Sedation | 2 | 2016 | 39 | 0.120 |
Why?
|
| Sarcoidosis | 1 | 2016 | 34 | 0.120 |
Why?
|
| Lymphoma | 1 | 2016 | 103 | 0.120 |
Why?
|
| Surveys and Questionnaires | 2 | 2020 | 2679 | 0.110 |
Why?
|
| Neoplasms, Hormone-Dependent | 1 | 2014 | 10 | 0.110 |
Why?
|
| Anoikis | 1 | 2014 | 7 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 16 | 0.110 |
Why?
|
| Self-Assessment | 3 | 2020 | 60 | 0.110 |
Why?
|
| Pleural Effusion | 1 | 2013 | 39 | 0.100 |
Why?
|
| Body Mass Index | 2 | 2020 | 866 | 0.100 |
Why?
|
| Lung Diseases | 1 | 2015 | 183 | 0.100 |
Why?
|
| CD24 Antigen | 1 | 2013 | 18 | 0.100 |
Why?
|
| Catheter-Related Infections | 1 | 2013 | 42 | 0.100 |
Why?
|
| Sulindac | 1 | 2012 | 5 | 0.100 |
Why?
|
| Nanotechnology | 1 | 2014 | 135 | 0.100 |
Why?
|
| Electromagnetic Phenomena | 1 | 2012 | 5 | 0.100 |
Why?
|
| Antigens, Surface | 1 | 2013 | 197 | 0.100 |
Why?
|
| Hematocrit | 1 | 2012 | 34 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2020 | 805 | 0.100 |
Why?
|
| Serum Albumin | 1 | 2012 | 47 | 0.100 |
Why?
|
| Adenocarcinoma | 1 | 2015 | 348 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2014 | 281 | 0.090 |
Why?
|
| Vital Capacity | 1 | 2012 | 118 | 0.090 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 86 | 0.090 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 507 | 0.090 |
Why?
|
| Anesthesia, Local | 1 | 2011 | 20 | 0.090 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2012 | 204 | 0.090 |
Why?
|
| Hypnotics and Sedatives | 1 | 2011 | 66 | 0.090 |
Why?
|
| Analgesia | 1 | 2011 | 31 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2018 | 1308 | 0.090 |
Why?
|
| Anesthetics, Local | 1 | 2011 | 71 | 0.090 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 205 | 0.090 |
Why?
|
| Analgesics | 1 | 2011 | 102 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2012 | 218 | 0.090 |
Why?
|
| Acute Disease | 1 | 2012 | 672 | 0.080 |
Why?
|
| Risk | 2 | 2021 | 377 | 0.080 |
Why?
|
| Risk Factors | 4 | 2014 | 5353 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2014 | 418 | 0.080 |
Why?
|
| Career Mobility | 2 | 2020 | 64 | 0.080 |
Why?
|
| Palliative Care | 2 | 2018 | 230 | 0.080 |
Why?
|
| Case-Control Studies | 1 | 2012 | 1122 | 0.080 |
Why?
|
| Tracheal Stenosis | 1 | 2008 | 9 | 0.070 |
Why?
|
| Faculty, Medical | 2 | 2023 | 198 | 0.070 |
Why?
|
| Health Services Accessibility | 1 | 2013 | 564 | 0.070 |
Why?
|
| Benchmarking | 2 | 2023 | 137 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2013 | 787 | 0.070 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 1652 | 0.070 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 663 | 0.070 |
Why?
|
| Respiratory Mucosa | 1 | 2007 | 54 | 0.070 |
Why?
|
| Intubation, Intratracheal | 1 | 2008 | 204 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2021 | 3290 | 0.060 |
Why?
|
| Treatment Outcome | 5 | 2019 | 5680 | 0.060 |
Why?
|
| Bronchial Neoplasms | 1 | 2004 | 6 | 0.060 |
Why?
|
| Stents | 2 | 2009 | 502 | 0.060 |
Why?
|
| Carcinoma, Small Cell | 1 | 2004 | 22 | 0.060 |
Why?
|
| Airway Obstruction | 1 | 2004 | 38 | 0.060 |
Why?
|
| Comorbidity | 2 | 2020 | 1123 | 0.060 |
Why?
|
| Cohort Studies | 3 | 2021 | 2569 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2007 | 523 | 0.050 |
Why?
|
| Bronchi | 2 | 2019 | 81 | 0.050 |
Why?
|
| Radiation Dosage | 2 | 2015 | 132 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 771 | 0.050 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2023 | 38 | 0.050 |
Why?
|
| Quality of Life | 2 | 2021 | 1228 | 0.050 |
Why?
|
| Massachusetts | 2 | 2020 | 2076 | 0.050 |
Why?
|
| Recurrence | 2 | 2017 | 641 | 0.050 |
Why?
|
| Citalopram | 1 | 2021 | 21 | 0.040 |
Why?
|
| Long QT Syndrome | 1 | 2021 | 32 | 0.040 |
Why?
|
| Denmark | 1 | 2020 | 17 | 0.040 |
Why?
|
| Organ Size | 1 | 2020 | 172 | 0.040 |
Why?
|
| Incidence | 2 | 2014 | 1377 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2021 | 182 | 0.040 |
Why?
|
| Body Composition | 1 | 2020 | 152 | 0.040 |
Why?
|
| Inhalation | 1 | 2019 | 12 | 0.040 |
Why?
|
| Specialization | 1 | 2020 | 81 | 0.040 |
Why?
|
| Aged, 80 and over | 4 | 2014 | 5456 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 2463 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2021 | 464 | 0.040 |
Why?
|
| Time Factors | 2 | 2017 | 3767 | 0.040 |
Why?
|
| Anti-Infective Agents | 1 | 2021 | 150 | 0.040 |
Why?
|
| Adult | 5 | 2021 | 16822 | 0.040 |
Why?
|
| Heart Diseases | 1 | 2021 | 218 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2021 | 555 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2018 | 193 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2017 | 144 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2018 | 173 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1559 | 0.030 |
Why?
|
| Deep Sedation | 1 | 2016 | 4 | 0.030 |
Why?
|
| Liver Transplantation | 1 | 2018 | 216 | 0.030 |
Why?
|
| Lymphatic Diseases | 1 | 2016 | 13 | 0.030 |
Why?
|
| Mediastinoscopy | 1 | 2015 | 8 | 0.030 |
Why?
|
| Hamartoma | 1 | 2015 | 12 | 0.030 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2015 | 19 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2009 | 582 | 0.030 |
Why?
|
| Granuloma | 1 | 2015 | 41 | 0.030 |
Why?
|
| Thoracotomy | 1 | 2015 | 46 | 0.030 |
Why?
|
| Simulation Training | 1 | 2016 | 65 | 0.030 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2015 | 61 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 2079 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2014 | 254 | 0.030 |
Why?
|
| Age Distribution | 1 | 2014 | 259 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 433 | 0.030 |
Why?
|
| Epithelial Cell Adhesion Molecule | 1 | 2013 | 3 | 0.030 |
Why?
|
| North America | 1 | 2013 | 111 | 0.030 |
Why?
|
| HT29 Cells | 1 | 2013 | 28 | 0.030 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2014 | 79 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2016 | 462 | 0.030 |
Why?
|
| Australia | 1 | 2013 | 120 | 0.030 |
Why?
|
| Europe | 1 | 2013 | 195 | 0.030 |
Why?
|
| Heterografts | 1 | 2013 | 63 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 167 | 0.030 |
Why?
|
| Interdisciplinary Studies | 1 | 2012 | 7 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2013 | 92 | 0.030 |
Why?
|
| Radiology Information Systems | 1 | 2013 | 34 | 0.020 |
Why?
|
| Chemoprevention | 1 | 2012 | 42 | 0.020 |
Why?
|
| Models, Organizational | 1 | 2013 | 93 | 0.020 |
Why?
|
| Antigens, Neoplasm | 1 | 2013 | 136 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2014 | 400 | 0.020 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 338 | 0.020 |
Why?
|
| Cell Survival | 1 | 2014 | 569 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 214 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 1148 | 0.020 |
Why?
|
| Survival Rate | 1 | 2013 | 851 | 0.020 |
Why?
|
| Regression Analysis | 1 | 2012 | 498 | 0.020 |
Why?
|
| Smoking Cessation | 1 | 2015 | 550 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 937 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2013 | 475 | 0.020 |
Why?
|
| Prognosis | 1 | 2013 | 1747 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1277 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 734 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2010 | 569 | 0.020 |
Why?
|
| Equipment Design | 1 | 2009 | 351 | 0.020 |
Why?
|
| Primary Health Care | 1 | 2013 | 690 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2010 | 1008 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 297 | 0.020 |
Why?
|
| Prosthesis Fitting | 1 | 2004 | 7 | 0.010 |
Why?
|
| Hemoptysis | 1 | 2004 | 8 | 0.010 |
Why?
|
| Foreign-Body Migration | 1 | 2004 | 23 | 0.010 |
Why?
|
| Device Removal | 1 | 2004 | 68 | 0.010 |
Why?
|
| Dyspnea | 1 | 2004 | 124 | 0.010 |
Why?
|
| Neoplasm Invasiveness | 1 | 2004 | 278 | 0.010 |
Why?
|
| Prosthesis Design | 1 | 2004 | 229 | 0.010 |
Why?
|
| Cough | 1 | 2004 | 183 | 0.010 |
Why?
|
| Biomarkers | 1 | 2007 | 1405 | 0.010 |
Why?
|
| Mice | 1 | 2013 | 10829 | 0.010 |
Why?
|
| Animals | 1 | 2013 | 20638 | 0.010 |
Why?
|